In one study, scientists fused the mVEGFR (vascular endothelial growth factor receptor) gene to the C-terminus of the T4-Soc gene, resulting in a recombinant phage that inhibited tumor angiogenesis in a mouse lung cancer model [40]. This evidence concerns the gene UBXN11 and lung carcinoma.